Perbedaan UBC Medical Indonesia Tbk. dan Multi Bintang Indonesia Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Multi Bintang Indonesia Tbk. diperdagangkan di Rp6.325 (kapitalisasi pasar 13,33 T, volume 24 jam 51,1 rb). Perbedaan utamanya: Multi Bintang Indonesia Tbk. jauh lebih besar — sekitar 23,1× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,48 jt vs 51,1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | MLBI | |
|---|---|---|
Kapitalisasi Pasar | 576,7 M | 13,33 T |
Volume | 3,48 jt | 51,1 rb |
Lot | 34,82 rb | 511 |
Perputaran | 522,79 jt | 322,91 jt |
Harga Rata-rata | 150,13 | 6.319,08 |
Nilai Transaksi | 522,79 jt | 322,91 jt |
Harga Ekuilibrium Indikatif | 148 | — |
Volume Ekuilibrium Indikatif | 350 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Multi Bintang Indonesia Tbk (The Company) was established on June 3, 1929, based on notarial deed No. 8 of Tjeerd Dijkstra, notary public in Medan, under the name of NV Nederlandsch Indische Bierbrouwerijen. The Company is part of the Heineken Group, where the ultimate shareholder is Heineken N.V. (Heineken).
Selengkapnya di halaman MLBI →